Register entry

Stellon Biotech Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
5
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

5

5 active NDC listings: 5 human prescription drug. By marketing category: ANDA 5.

Dosage formNDCs
capsule3
tablet, delayed release2
RouteNDCs
oral5
Labeller name on the listingNDCs
stellon biotech inc.5
Catalogue

Marketed products

5
BrandGeneric nameForm / routeNDC
TacrolimusTacrolimuscapsule, oral85972-101ANDA
TacrolimusTacrolimuscapsule, oral85972-102ANDA
TacrolimusTacrolimuscapsule, oral85972-103ANDA
mycophenolic acidmycophenolic acidtablet, delayed release, oral85972-161ANDA
mycophenolic acidmycophenolic acidtablet, delayed release, oral85972-162ANDA
Compare

Other companies listing tacrolimus

Enquiry

Common questions

Is Stellon Biotech Inc. FDA approved?
Stellon Biotech Inc. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Stellon Biotech Inc. make?
5 products are listed under Stellon Biotech Inc. in the openFDA NDC Directory, most often as capsule; tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.